| 3 | 1/1 | 返回列表 |
| 查看: 395 | 回復: 2 | ||
葬花公子鐵桿木蟲 (著名寫手)
General
|
[求助]
求賽來昔布(Celecoxibum)在USP36以上的質量標準 已有1人參與
|
| 各位大蝦,緊急求助Celecoxibum的最新質量標準,最好是膠囊或制劑的,原料的EP7.5和USP35的標準我自己就有,USP36的沒有,求各位幫忙!~ |

金蟲 (正式寫手)
|
Celecoxib (sel'' e kox' ib). C17H14F3N3O2S 381.4 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide; p-[5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide [169590-42-5]. DEFINITION Celecoxib contains NLT 98.0% and NMT 102.0% of C17H14F3N3O2S, calculated on the anhydrous basis. IDENTIFICATION A. Infrared Absorption 197: [Note??Methods 197A, 197K, or 197M under Infrared Absorption may be used. ] [Note??If the spectra obtained show differences, dissolve the substance to be examined and the Reference Standard separately in isopropyl alcohol, evaporate to dryness, and record the new spectra. ] B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. ASSAY Procedure Buffer: 2.7 g/L of monobasic potassium phosphate adjusted with phosphoric acid to a pH of 3.0 ?? 0.2 Mobile phase: Methanol, acetonitrile, and Buffer (3:1:6) Diluent: Methanol and water (3:1) System suitability solution: 0.5 mg/mL of USP Celecoxib RS and 2.4 ??/mL each of USP Celecoxib Related Compound A RS and USP Celecoxib Related Compound B RS in Diluent Standard solution: 0.5 mg/mL of USP Celecoxib RS in Diluent Sample solution: 0.5 mg/mL of Celecoxib in Diluent Chromatographic system (See Chromatography 621, System Suitability.) Mode: LC Detector: UV 215 nm Column: 4.6-mm ?? 25-cm; 5-?? packing L11 Column temperature: 60 Flow rate: 1.5 mL/min Injection size: 25 L Run time: About 1.5 times the celecoxib peak elution System suitability Samples: System suitability solution and Standard solution Suitability requirements Resolution: NLT 1.8 between celecoxib related compound A and celecoxib and NLT 1.8 between celecoxib and celecoxib related compound B, System suitability solution Relative standard deviation: NMT 0.73%, Standard solution Analysis Samples: Standard solution and Sample solution Calculate the percentage of C17H14F3N3O2S in the portion of Celecoxib taken: Result = (rU/rS) ?? (CS/CU) ?? 100 rU = = peak response from the Sample solution rS = = peak response from the Standard solution CS = = concentration of the Standard solution (mg/mL) CU = = concentration of the Sample solution (mg/mL) Acceptance criteria: 98.0%?C102.0% on the anhydrous basis IMPURITIES Inorganic Impurities Heavy Metals: NMT 20 ppm Diluent: Acetone and water (17:3) Standard solution: Dilute 1.0 mL of Standard Lead Solution, prepared as directed under Heavy Metals 231, Special Reagents, with Diluent to 20 mL. Sample solution: Dissolve 0.50 g of Celecoxib in 20 mL of Diluent. Blank solution: 20 mL of Diluent Analysis Samples: Standard solution, Blank solution, and Sample solution To each solution, add 2 mL of pH 3.5 Acetate Buffer, prepared as directed under Heavy Metals 231, Method I. Mix, and add to each solution 1.2 mL of thioacetamide?Cglycerin base TS. Mix immediately, and allow to stand for 2 min. Pass the solutions through a filter of 0.45-?? pore size. Compare the spots on the filters obtained from each of the solutions. Acceptance criteria: The brownish-black color of the spot resulting from the Sample solution is not more intense than that of the spot resulting from the Standard solution. The test is invalid if the Standard solution does not show a brownish-black color compared to the Blank solution. Residue on Ignition 281: NMT 0.2%, using a platinum crucible Organic Impurities Procedure Buffer, Mobile phase, Diluent, System suitability solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay. Standard solution: 0.5 ??/mL of USP Celecoxib RS in Diluent System suitability Samples: System suitability solution and Standard solution Suitability requirements Resolution: NLT 1.8 between celecoxib related compound A and celecoxib and NLT 1.8 between celecoxib and celecoxib related compound B, System suitability solution Signal-to-noise ratio: NLT 20, Standard solution Analysis Samples: Standard solution and Sample solution Calculate the percentage of each impurity in the portion of Celecoxib taken: Result = (rU/rS) ?? (CS/CU) ?? 100 rU = = peak response for each impurity in the Sample solution rS = = peak response of celecoxib in the Standard solution CS = = concentration of celecoxib in the Standard solution (mg/mL) CU = = concentration of Celecoxib in the Sample solution (mg/mL) Acceptance criteria Individual impurities: See Table 1. [Note??Disregard any impurity peak less than 0.05%. ] Table 1 Name Relative Retention Time Acceptance Criteria, NMT (%) Celecoxib related compound Aa 0.9 0.4 Celecoxib 1.0 ?? Celecoxib related compound Bb 1.1 0.10 Individual unspecified impurity ?? 0.10 Total impurities ?? 0.5 a 4-[5-(3-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide. b 4-[3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide. SPECIFIC TESTS Water Determination, Method I 921: NMT 0.5%, using a 400-mg sample ADDITIONAL REQUIREMENTS Packaging and Storage: Preserve in tight containers, protected from light and moisture. Store at room temperature. USP Reference Standards 11 USP Celecoxib RS p-[5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide. C17H14F3N3O2S 381.4 USP Celecoxib Related Compound A RS 4-[5-(3-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide. C17H14F3N3O2S 381.4 USP Celecoxib Related Compound B RS 4-[3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide. C17H14F3N3O2S 381.4 Auxiliary Information?? Please check for your question in the FAQs before contacting USP. Topic/Question Contact Expert Committee Monograph Hillary Z Cai Scientific Liaison, Small Molecules (301) 230-3379 (SM22010) Monographs - Small Molecules 2 Reference Standards RS Technical Services 1-301-816-8129 rstech@usp.org USP37?CNF32 Page 2246 Pharmacopeial Forum: Volume No. 36(6) Page 1519 Chromatographic Column?? CELECOXIB Chromatographic columns text is not derived from, and not part of, USP 37 or NF 32. |

金蟲 (正式寫手)

| 3 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[基金申請] 請教下大家 2026年國家基金申請是雙盲審嗎? +3 | lishucheng1 2026-03-22 | 5/250 |
|
|---|---|---|---|---|
|
[考研] 341求調劑(一志愿湖南大學070300) +5 | 番茄頭--- 2026-03-22 | 6/300 |
|
|
[考研] 085600材料與化工調劑 +7 | A-哆啦Z夢 2026-03-23 | 12/600 |
|
|
[考研] 一志愿國科過程所081700,274求調劑 +3 | 三水研0水立方 2026-03-23 | 3/150 |
|
|
[考研] 考研化學308分求調劑 +7 | 你好明天你好 2026-03-23 | 8/400 |
|
|
[考研] 生物學一志愿985,分數(shù)349求調劑 +6 | zxts12 2026-03-21 | 9/450 |
|
|
[考研] 一志愿中國石油大學(華東) 本科齊魯工業(yè)大學 +4 | 石能偉 2026-03-17 | 4/200 |
|
|
[論文投稿] 急發(fā)核心期刊論文 +3 | 賢達問津 2026-03-23 | 5/250 |
|
|
[考研] 350求調劑 +6 | weudhdk 2026-03-19 | 6/300 |
|
|
[考研] 招08考數(shù)學 +6 | laoshidan 2026-03-20 | 14/700 |
|
|
[考研] 269專碩求調劑 +6 | 金恩貝 2026-03-21 | 6/300 |
|
|
[考研] 354求調劑 +7 | Tyoumou 2026-03-18 | 10/500 |
|
|
[考博] 招收博士1-2人 +3 | QGZDSYS 2026-03-18 | 4/200 |
|
|
[考研] 一志愿深大,0703化學,總分302,求調劑 +4 | 七月-七七 2026-03-21 | 4/200 |
|
|
[考研] 求調劑 +3 | 白QF 2026-03-21 | 3/150 |
|
|
[考研] 083200學碩321分一志愿暨南大學求調劑 +3 | innocenceF 2026-03-17 | 3/150 |
|
|
[考研] 求調劑 +3 | Ma_xt 2026-03-17 | 3/150 |
|
|
[考研] 296求調劑 +6 | www_q 2026-03-18 | 10/500 |
|
|
[考研] 一志愿蘇州大學材料求調劑,總分315(英一) +5 | sbdksD 2026-03-19 | 5/250 |
|
|
[考研] 085600材料與化工求調劑 +6 | 緒幸與子 2026-03-17 | 6/300 |
|